Faheem Hasnain's Net Worth

$32.5 Million

Estimate Recalculated Nov 8, 2024 04:31PM EST

Who is Faheem Hasnain?

Faheem Hasnain has an estimated net worth of $32.5 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC, TERCICA INC, FACET BIOTECH CORP, Panacea Acquisition Corp, Receptos, Inc., Mirati Therapeutics, Inc., Kura Oncology, Inc., VITAL THERAPIES INC, Gossamer Bio, Inc., Tocagen Inc, PDL BIOPHARMA, INC., AMBIT BIOSCIENCES CORP, and Pernix Sleep, Inc..

SEC CIK

Faheem Hasnain's CIK is 0001352620

Past Insider Trading and Trends

2008 was Faheem Hasnain's most active year for acquiring shares with 8 total transactions. Faheem Hasnain's most active month to acquire stocks was the month of January. 2008 was Faheem Hasnain's most active year for disposing of shares, totalling 33 transactions. Faheem Hasnain's most active month to dispose stocks was the month of March. 2008 saw Faheem Hasnain paying a total of $1,384,247.75 for 872,782 shares, this is the most they've acquired in one year. In 2015 Faheem Hasnain cashed out on 799,849 shares for a total of $80,664,086.13, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN IDEC INC (BIIB) Snapshot price: $200.5

EVP, Oncology/Rheumatology SBU

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.74%
-6.66K
$53.97
-$902,357.30
25.45K
Scheduled
Jul 9
Form 4
-16.67%
-6.42K
$64.47
-$414,207.94
32.12K
Scheduled
Apr 8
Form 4
+29.36%
8.64K
$60.56
-$108,281.28
38.08K
Feb 12
Form 4
+13.28%
3.45K
$60.52
-$122,068.84
29.43K
Feb 6
Form 4
+11.63%
2.7K
—
—
25.92K
Nov 1
Form 4
-13.45%
-3.58K
$65.88
-$235,521.00
23.01K
Oct 4
Form 4/A
-22.13%
-7.45K
$49.00
-$364,854.00
26.21K
Scheduled
May 23
Form 4
-22.33%
-7.45K
$49.00
-$364,854.00
25.9K
Scheduled
May 23
Form 4
+13.63%
4K
$44.11
-$98,188.86
33.34K
Mar 14
Form 4
+13.63%
4K
$44.11
-$98,188.86
33.34K
Mar 14
Form 4
+104.57%
15K
—
—
29.34K
Feb 12
Form 4
+31.63%
3.45K
$48.94
-$98,858.80
14.34K
Feb 6
Form 4
-51.02%
-11.24K
$44.63
-$501,766.80
10.79K
Scheduled
Oct 2
Form 4
+105.05%
11.24K
$43.39
-$271,447.84
21.95K
Sep 14
Form 4
—
0
—
—
0
Feb 6
Form 3
—
0
—
—
0
No matching records found

TERCICA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 16
Form 4
—
0
—
—
0
Feb 27
Form 3
—
0
—
—
0
No matching records found

FACET BIOTECH CORP No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-102.67K
$27.00
-$2,772,009.00
0
Apr 21
Form 4
-15.24%
-18.46K
$27.00
-$498,501.00
102.67K
Apr 20
Form 4
-6.94%
-8.94K
$17.37
-$155,235.69
119.93K
Oct 1
Form 4
+27.67%
27.67K
—
—
127.67K
Aug 6
Form 4
∞
100K
—
—
100K
Jan 23
Form 3
—
0
—
—
0
No matching records found

Panacea Acquisition Corp (NUVB) Snapshot price: $2.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
55K
$10.00
$300,000.00
55K
Feb 10
Form 3
—
0
—
—
0
No matching records found

Receptos, Inc. No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-416.91K
—
—
0
Aug 25 - Aug 27
Form 4
+8.45%
32.5K
—
—
416.91K
Apr 1
Form 4
-34.05%
-200.00K
$109.47
-$21,893,756.50
387.41K
Scheduled
Nov 10 - Nov 11
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jul 17
Form 4
+8.87%
47.62K
$5.25
$249,994.50
584.41K
May 14
Form 3
—
0
—
—
0
No matching records found